Tenofovir plus didanosine as Nrti backbone in HIV-infected subjects

Current Medicinal Chemistry

Volumn 13, Issue 23, 2006, Pages 2789-2793

  Bongiovanni, Marco ^a   Tordato, Federica ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Didanosine; NRTI; Pharmacokinetic; Tenofovir; Virological failure

Indexed keywords

DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PLACEBO; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

AREA UNDER THE CURVE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COMPETITIVE INHIBITION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG TREATMENT FAILURE; FOOD DRUG INTERACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; KIDNEY CLEARANCE; LACTIC ACIDOSIS; PANCREATITIS; REVIEW; RISK ASSESSMENT; SALVAGE THERAPY; TREATMENT OUTCOME;

ADENINE; ANTI-HIV AGENTS; DIDANOSINE; DRUG ANTAGONISM; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33749445648     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986706778521931     Document Type: Review

References (32)

1. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents., May 4, 2006. Date of last access: June 2006.
2. Pecora, F.P.; Kirian, M.A. E. Ann. Pharmacother. 2003, 37, 1325-1328.
3. Ray, A.S.; Olson, L.; Fridland, A. Antimicrob. Agents Chemother. 2004, 48, 1089-1095.
4. Havlir, D.V.; Tierney, C.; Friedland, G.H.; Pollard, R. B.; Smeaton, L.; Sommadossi, J.P.; Fox, L.; Kessler, H.; Fife, K.H.; Richman, D.D. J. Infect. Dis. 2000, 182, 321-325.
5. Hoggard, P.G.; Kewn, S.; Barry, M.G.; Khoo, S.H.; Back, D.J. Antimicrob. Agents Chemother. 1997, 41, 1231-1236.
6. Kewn, S.; Veal, G.J., Hoggard, P.G.; Barry, M.G.; Beck, D.J. Biochem. Pharmacol. 1997, 54, 589-595.
7. Pruvost, A.; Negredo, E.; Benech, H.; Theodoro, F.; Puig, J.; Grau, E.; Garcia, E.; Molto, J.; Grassi, J.; Clotet, B. Antimicrob. Agents Chemother. 2005, 49, 1907-1914.
8. Kearney, B.P.; Sayre, J.R.; Flaherty, J.F.; Chen, S.S.; Kaul, S.; Cheng, A.K. J. Clin. Pharmacol. 2005, 45, 1360-1367.
9. Leon, A.; Martinez, E.; Mallolas, J.; Laguno, M.; Blanco, J.L.; Pumarola, T.; Gatell, J.M. AIDS 2005, 19, 213-215.
10. Podzamczer, D.; Ferrer, E.; Gatell, J.M.; Niubo, J.; Dalmau, D.; Leon, A.; Knobel, H.; Polo, C.; Iniguez, D.; Ruiz, I. Antivir. Ther. 2005, 10, 171-177.
11. Torti, C.; Quiros-Roldon, E.; Ragazzi, M.; Antinori, A.; Patroni, A.; Villani, P.; Tirelli, V.; Cologni, G.; Zinzi, D.; Lo Capito, S.; Perini, P.; Carosi, G. Antivir. Ther. 2005, 10, 505-513.
12. Maitland, D.; Moyle, G.; Hand, J.; Mandalia, S.; Boffito, M.; Nelson, M.; Gazzard, B. AIDS 2005, 19, 1183-1188.
13. Barrios, A.; Rendon, A.; Negredo, E.; Barreiro, P.; Garcia-Benayas, T.; Labarga, P.; Santos, J.; Domingo, P.; Sanchez-Conde, M.; Maida, L; Martin-Carbonero, L.; Nunez, M.; Blanco, F.; Clotet, B.; Sambeat, M.A.; Gil, P.; Gonzalez-Lahoz, J.; Cooper, D.; Soriano, V. AIDS 2005, 19, 569-575.
14. Leon, A.; Mallolas, J.; Martinez, E., De Lazzari, E.; Pumarola, T.; Larrousse, M.; Milincovic, A.; Lonca, M.; Blanco, J.L.; Laguno, M.; Biglia, A.; Gatell, J.M. AIDS 2005, 19, 1695-1697.
15. Perez-Elias, M.J.; Moreno, S.; Gutierrez, C.; Lopez, D.; Abraira, V.; Moreno, A.; Dronda, F.; Casado, J.L.; Antela, A.; Rodriguez, M.A. AIDS 2005, 19, 695-98.
16. Negredo, E.; Moltò, J.; Burger, D.; Viciana, P.; Ribera, E.; Paredes, R.; Juan, M.; Ruiz, L.; Puig, J.; Pruvost, A.; Grassi, J.; Masmitjà, E.; Clotet, B. AIDS 2004, 18, 459-463.
17. Negredo, E.; Moltò, J.; Munoz-Moreno, J.A.; Pedrol, E.; Ribera, E.; Viciana, P.; Galindos, M.J.; Miralles, C.; Burger, D.; Rodriguez-Fumaz, C.; Puig, J.; Gel, S.; Rodriguez, E.; Videla, S.; Ruiz, L.; Clotet, B. Antivir. Ther. 2004, 9, 335-342.
18. Barrios, A.; Negredo, E.; Domingo, P.; Estrada, V.; Labarga, P.; Asensi, V.; Morales, D.; Santos, J.; Clotet, B.; Soriano, V. Antivir. Ther. 2005, 10, 825-832.
19. Lacombe, K.; Pacanowski, J.; Meynard, J.L.; Trylesinski, A.; Girard, P.M. AIDS 2005, 19, 1107-1108.
20. Tung, M.Y.; Mandalia, S.; Bower, M.; Gazzard, B.; Nelson, M. HIV Med 2005, 6, 151-154.
21. Karrer, U.; Ledergerber, B.; Furrer, H.; Elzi, L.; Battegay, M.; Cavassini, M.; Gayet-Ageron, A.; Hirschel, B.; Schmid, P.; Russotti, M.; Weber, R.; Speck, R.F. AIDS 2005, 19, 1987-1994.
22. Negredo, E.; Bonjoch, A.; Paredes, R.; Puig, J.; Clotet, B. Clin. Infect. Dis. 2005, 41, 901-905.
23. Gianotti, N.; Seminari, E.; Fusetti, G.; Salpietro, S.; Boeri, E.; Galli, A.; Lazzarin, A.; Clementi, M.; Castagna, A. AIDS 2004, 18, 2205-2207.
24. Becher, F.; Landman, R.; Mboup, S.; Kane, C.N.; Canestri, A.; Liegeois, F.; Vray, M.; Prevot, M.H.; Leleu, G.; Benech, H. AIDS 2004, 18, 181-187.
25. Masia, M.; Gutierrez, F.; Padilla, S.; Ramos, J.M.; Pascual, J. Intern. J. STD AIDS 2005, 16, 646-648.
26. Blanchard, J.N.; Wohlfeiler, M.; Canas, A.; King, K.; Lonergan, J.T. Clin. Infect. Dis. 2003, 37, 57-62.
27. Murphy, M.D.; O'Hearn, M.; Chou, S. Clin. Infect. Dis. 2003, 36, 1082-1085.
28. Callens, S.; De Schacht, C.; Huyst, V.; Colebunders, R. J. Infect. 2003, 47, 188-189.
29. Rivas,P.; Polo, J.; de Gorgolas, M.; Fernandez-Guerrero, M.L. BMJ 2003, 327, 711.
30. Gallant J.E.; Deresinski, S. Clin. Infect. Dis. 2003, 37, 944-950.
31. Martinez, E.; Milinkovic, A.; de Lazzari, E.; Ravasi, G.; Blanco, J.L.; Larrousse, M.; Mallolas, J.; Garcia, F.; Mirò, J.M.; Gatell, J.M. Lancet 2004, 364, 65-67.
32. Moreno, A.; Quereda, C.; Moreno, L.; Perez-Elias, M.J.; Muriel, A.; Casado, J.L.; Antela, A.; Dronda, F.; Navas, E.; Barcena, R.; Moreno, S. Antivir. Ther. 2004, 9, 133-138.